Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the quick ratio (acid-test) high or low?
The quick ratio (acid-test) of 4.36 is in line with its 5-year average of 4.48, near the low end of its 5-year range (1.79–18.08).
As of the fiscal period ended Tuesday, June 30, 2026. 9.02% above its 12-month average of 4.00.
Reported quarterly quick ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 4.36.
QUICK RATIO (ACID-TEST)
4.36
QUICK RATIO (ACID-TEST) AVG TTM
4.00
QUICK RATIO (ACID-TEST) AVG 3Y
3.01
QUICK RATIO (ACID-TEST) AVG 5Y
4.48
QUICK RATIO (ACID-TEST) AVG 10Y
N/A
QUICK RATIO (ACID-TEST) AVG 15Y
N/A
QUICK RATIO (ACID-TEST) AVG 20Y
N/A
CURRENT VS TTM AVG
+9.02%
CURRENT VS 3Y AVG
+44.78%
CURRENT VS 5Y AVG
-2.64%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.20
median of 756 covered companies
CURRENT VS SECTOR MEDIAN
+36.45%
vs the sector median at left
Gain Therapeutics, Inc.
Market Cap
$72.51M
Quick Ratio (Acid-Test)
4.36
TTM Avg
4.00
3Y Avg
3.01
5Y Avg
4.48
Market Cap
$69.31M
Quick Ratio (Acid-Test)
1.75
TTM Avg
2.29
3Y Avg
2.05
5Y Avg
3.32
Market Cap
$74.77M
Quick Ratio (Acid-Test)
5.45
TTM Avg
4.61
3Y Avg
8.17
5Y Avg
10.19
Market Cap
$75.91M
Quick Ratio (Acid-Test)
1.48
TTM Avg
3.70
3Y Avg
5.52
5Y Avg
5.98
Market Cap
$76.13M
Quick Ratio (Acid-Test)
4.11
TTM Avg
4.89
3Y Avg
5.09
5Y Avg
6.08
Market Cap
$68.27M
Quick Ratio (Acid-Test)
3.83
TTM Avg
1.68
3Y Avg
1.58
5Y Avg
2.46
Market Cap
$78.35M
Quick Ratio (Acid-Test)
3.52
TTM Avg
4.58
3Y Avg
5.82
5Y Avg
8.88
Market Cap
$68.84M
Quick Ratio (Acid-Test)
1.03
TTM Avg
0.95
3Y Avg
0.86
5Y Avg
0.95
| NAME | MARKET CAP | QUICK RATIO (ACID-TEST) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Gain Therapeutics, Inc. (GANX) | $72.51M | 4.36 | 4.00 | 3.01 | 4.48 |
| MindWalk Holdings Corp. (HYFT)vs › | $69.31M | 1.75 | 2.29 | 2.05 | 3.32 |
| Hyperfine, Inc. (HYPR)vs › | $74.77M | 5.45 | 4.61 | 8.17 | 10.19 |
| SkinHealth Systems Inc. (SKIN)vs › | $75.91M | 1.48 | 3.70 | 5.52 | 5.98 |
| Outset Medical, Inc. (OM)vs › | $76.13M | 4.11 | 4.89 | 5.09 | 6.08 |
| iBio, Inc. (IBIO)vs › | $69.13M | 7.85 | 4.72 | 3.68 | 5.30 |
| Fortress Biotech, Inc. (FBIO)vs › | $68.27M | 3.83 | 1.68 | 1.58 | 2.46 |
| Pulmonx Corporation (LUNG)vs › | $78.35M | 3.52 | 4.58 | 5.82 | 8.88 |
| Champions Oncology, Inc. (CSBR)vs › | $68.84M | 1.03 | 0.95 | 0.86 | 0.95 |
| Neonc Technologies Holdings, Inc. (NTHI)vs › | $78.05M | 0.14 | 0.07 | 0.07 | 0.07 |
Quick Ratio
4.36
Excludes inventory
Current Ratio
4.36
Includes inventory
Quick Ratio = (Current Assets − Inventory) / Current Liabilities
The quick ratio is a stricter liquidity measure that excludes inventory, showing the ability to meet short-term obligations with the most liquid assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | QUICK RATIO (ACID-TEST) |
|---|---|
| 2026-06-30 | 4.36 |
| 2026-03-31 | 4.69 |
| 2025-12-31 | 6.63 |
| 2025-09-30 | 2.52 |
| 2025-06-30 | 1.79 |
| 2025-03-31 | 2.22 |
| 2024-12-31 | 2.97 |
| 2024-09-30 | 2.99 |
| 2024-06-30 | 2.84 |
| 2024-03-31 | 2.77 |
| 2023-12-31 | 3.59 |
| 2023-09-30 | 2.30 |
| 2023-06-30 | 3.10 |
| 2023-03-31 | 3.75 |
| 2022-12-31 | 5.11 |
| 2022-09-30 | 5.62 |
| 2022-06-30 | 7.58 |
| 2022-03-31 | 8.63 |
| 2021-12-31 | 14.78 |
| 2021-09-30 | 11.62 |
| 2021-06-30 | 18.08 |
| 2021-03-31 | 20.37 |
| 2020-12-31 | 4.25 |
| 2020-09-30 | 10.82 |
| 2020-06-30 | 0.00 |
| 2020-03-31 | 0.00 |
| 2019-12-31 | 0.45 |
| 2019-09-30 | 0.49 |
| 2019-06-30 | 0.49 |
| 2019-03-31 | 0.49 |
| 2018-09-30 | 0.00 |
| 2018-06-30 | 0.00 |
| 2018-03-31 | 0.00 |
